China SXT Pharmaceuticals (China SXT Pharmaceuticals) Total Assets : $14.59 Mil (As of Sep. 2023)

View and export this data going back to 2019. Start your Free Trial

What is China SXT Pharmaceuticals Total Assets?

China SXT Pharmaceuticals's Total Assets for the quarter that ended in Sep. 2023 was $14.59 Mil.

During the past 12 months, China SXT Pharmaceuticals's average Total Assets Growth Rate was -83.70% per year. During the past 3 years, the average Total Assets Growth Rate was -5.40% per year. During the past 5 years, the average Total Assets Growth Rate was 16.70% per year.

During the past 7 years, China SXT Pharmaceuticals's highest 3-Year average Total Assets Growth Rate was 44.00%. The lowest was -5.40%. And the median was 34.15%.

Total Assets is connected with ROA %. China SXT Pharmaceuticals's annualized ROA % for the quarter that ended in Sep. 2023 was -87.86%. Total Assets is also linked to Revenue through Asset Turnover. China SXT Pharmaceuticals's Asset Turnover for the quarter that ended in Sep. 2023 was 0.04.

China SXT Pharmaceuticals Total Assets Historical Data

The historical data trend for China SXT Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China SXT Pharmaceuticals Total Assets Chart

China SXT Pharmaceuticals Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Assets

Get a 7-Day Free Trial

17.47

21.70

34.55

33.55

29.55

China SXT Pharmaceuticals Semi-Annual Data
	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Total Assets	Get a 7-Day Free Trial									22.67	33.55	22.18	29.55	14.59

China SXT Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

China SXT Pharmaceuticals's Total Assets for the fiscal year that ended in Mar. 2023 is calculated as

Total Assets	=	Total Equity (A: Mar. 2023 )	+	Total Liabilities (A: Mar. 2023 )
	=	14.691	+	14.863
	=	29.55

China SXT Pharmaceuticals's Total Assets for the quarter that ended in Sep. 2023 is calculated as

Total Assets	=	Total Equity (Q: Sep. 2023 )	+	Total Liabilities (Q: Sep. 2023 )
	=	5.076	+	9.512
	=	14.59

China SXT Pharmaceuticals (NAS:SXTC) Total Assets Explanation

Total Assets is connected with ROA %.

China SXT Pharmaceuticals's annualized ROA % for the quarter that ended in Sep. 2023 is

ROA %	=	Net Income (Q: Sep. 2023 )	/	( (Total Assets (Q: Mar. 2023 )	+	Total Assets (Q: Sep. 2023 ))	/ count )
	=	-19.392	/	( (29.554	+	14.588)	/ 2 )
	=	-19.392	/	22.071
	=	-87.86 %

Note: The Net Income data used here is two times the semi-annual (Sep. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

China SXT Pharmaceuticals's Asset Turnover for the quarter that ended in Sep. 2023 is

	Asset Turnover
=	Revenue (Q: Sep. 2023 )	/	( (Total Assets (Q: Mar. 2023 )	+	Total Assets (Q: Sep. 2023 ))	/ count )
=	0.94	/	( (29.554	+	14.588)	/ 2 )
=	0.94	/	22.071
=	0.04

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

China SXT Pharmaceuticals Total Assets Related Terms

Thank you for viewing the detailed overview of China SXT Pharmaceuticals's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

China SXT Pharmaceuticals (China SXT Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China SXT Pharmaceuticals Inc (NAS:SXTC) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

2RY0:Germany

Address

No. 178 Taidong Road North, Jiangsu, Taizhou, CHN, 225300

Website

http://www.sxtchina.com

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, Advanced TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates a majority of its revenue from the People's Republic of China.